Ketotifen Fumarate Ophthalmic Clinical Trials

• Safety and Efficacy Comparison Ketotifen Ophthalmic Solution with Emedastine in Patients with Seasonal Allergic Conjunctivitis
  ClinicalTrials.gov Identifier: NCT00133627 - Completed
  Seasonal allergic conjunctivitis
  
• Safety Study of a Contact Lens With Ketotifen in Healthy, Normal Volunteers
  ClinicalTrials.gov Identifier: NCT00569777 - Active, not recruiting
  Allergic Conjunctivitis
  
• TOBRADEX Ophthalmic Suspension Versus Tobramycin 0.3%/Dexamethasone 0.05% Ophthalmic Suspension
  ClinicalTrials.gov Identifier: NCT00576251 - Recruiting
  Ocular Inflammation Associated With Blepharaconjunctivitis
  
• The Safety of Tenofovir Disoproxil Fumarate Taken with Other Anti-HIV Drugs to Treat HIV-Infected Patients
  ClinicalTrials.gov Identifier: NCT00007436 - Active, not recruiting
  HIV Infections
  
• Tenofovir Disoproxil Fumarate in HIV-Infected Patients Who Have Not Had Success with Other Anti-HIV Drug Combinations
  ClinicalTrials.gov Identifier: NCT00011089 - Active, not recruiting
  HIV Infections
  
• Study of Treatment of Antiretroviral-Naive, HIV-1-Infected Patients Comparing Tenofovir Disoproxil Fumarate Administered in Combination with Lamivudine and Efavirenz Vs. Stavudine, Lamivudine and Efavirenz.
  ClinicalTrials.gov Identifier: NCT00158821 - Active, not recruiting
  HIV-1
  
• Tenofovir Disoproxil Fumarate (DF)/Emtricitabine/Efavirenz Versus Combivir/Efavirenz in Antiretroviral-Naive HIV-1 Infected Subjects
  ClinicalTrials.gov Identifier: NCT00112047 - Active, not recruiting
  HIV Infections
  
• Effect of Tenofovir Disoproxil Fumarate on Lipid Levels in HIV Infected Adults on Stable Anti-HIV Drug Therapy
  ClinicalTrials.gov Identifier: NCT00109603 - Active, not recruiting
  HIV Infections; Dyslipidemia; Hyperlipidemia; Hypercholesterolemia; Hypertriglyceridemia
  
• Safety and Blood Levels of Tenofovir Disoproxil Fumarate in HIV Infected Pregnant Women and Their Babies
  ClinicalTrials.gov Identifier: NCT00120471 - Recruiting
  HIV Infections
  
• Efavirenz Or Atazanazir/Ritonavir Given with Emtricitabine/Tenofovir Disoproxil Fumarate Or Abacavir/Lamivudine in HIV Infected Treatment-Naive Adults
  ClinicalTrials.gov Identifier: NCT00118898 - Active, not recruiting
  HIV Infections
  
• Safety of Tenofovir Disoproxil Fumarate (TDF) in HIV Infected Pregnant Women and Their Infants
  ClinicalTrials.gov Identifier: NCT00076791 - Recruiting
  HIV Infections
  
• Immediate Versus Deferred Start of Anti-HIV Therapy in HIV Infected Adults Being Treated for Tuberculosis
  ClinicalTrials.gov Identifier: NCT00108862 - Recruiting
  HIV Infections; Tuberculosis
  
• Study of Efficacy and Safety of Seroquel (Quetiapine Fumarate) as Mono-Therapy for Acute Schizophrenic
  ClinicalTrials.gov Identifier: NCT00428350 - Active, not recruiting
  Schizophrenia
  
• Effectiveness of Nucleoside Supplementation and Substituting Tenofovir Disoproxil Fumarate for Other Drugs in Anti-HIV Regimens in Reversing Fat Loss in HIV Infected Adults
  ClinicalTrials.gov Identifier: NCT00119379 - Recruiting
  HIV Infections; Lipodystrophy; Metabolic Diseases; Nutrition Disorders
  
• Combigan Ophthalmic Solution(Brimonidine 0.2% and Timolol 0.5%)With Latanoprost Compared With Latanoprost Monotherapy
  ClinicalTrials.gov Identifier: NCT00442312 - Active, not recruiting
  Glaucoma
  
• Phase III, Long-Term, Open-Label, Extension Study of 0.1% Tacrolimus(FK506) Ophthalmic Suspension in Patients With Vernal Keratoconjunctivitis
  ClinicalTrials.gov Identifier: NCT00567918 - Active, not recruiting
  Keratoconjunctivitis; Conjunctivitis
  
• One Hour Preoperative Gatifloxacin
  ClinicalTrials.gov Identifier: NCT00350363 - Recruiting
  Ophthalmic Surgery
  
• The Safety and Effectiveness of PMPA Prodrug in HIV-Infected Patients
  ClinicalTrials.gov Identifier: NCT00002396 - Active, not recruiting
  HIV Infections
  
• Montelukast Post-Marketing Comparative Study With Ketotifen
  ClinicalTrials.gov Identifier: NCT00446056 - Completed
  Asthma
  
• Efficacy and Safety Study for Ecabet Ophthalmic Solution for Treating Dry Eye Syndrome
  ClinicalTrials.gov Identifier: NCT00370747 - Active, not recruiting
  Dry Eye Syndromes
  
• Evaluation of the Onset and Duration of Action of Bepotastine Besilate Ophthalmic Solution in Acute Allergic Conjunctivitis
  ClinicalTrials.gov Identifier: NCT00424398 - Active, not recruiting
  Conjunctivitis, Allergic
  
• Safety/Efficacy of Bromfenac Ophthalmic Solution for Ocular Inflammation and Pain Associated With Cataract Surgery
  ClinicalTrials.gov Identifier: NCT00333918 - Active, not recruiting
  Pain; Inflammation
  
• Efficacy and Safety of Topical Bromfenac Ophthalmic Solution vs. Placebo in Subjects With Allergic Conjunctivitis
  ClinicalTrials.gov Identifier: NCT00423007 - Active, not recruiting
  Allergic Conjunctivitis
  
• Evaluation of Efficacy of Ophthalmic Solution in Induced Acute Allergic Conjunctivitis
  ClinicalTrials.gov Identifier: NCT00241319 - Active, not recruiting
  Allergic Conjunctivitis
  
• Quetiapine Fumarate (SEROQUEL) in the Treatment of Adolescent Patients With Schizophrenia and Bipolar I Disorder
  ClinicalTrials.gov Identifier: NCT00227305 - Active, not recruiting
  Schizophrenia; Bipolar I Disorder
  
• Comparing the Safety, Effectiveness, and Tolerability of Three Anti-HIV Drug Regimens for Treatment-Naive Patients
  ClinicalTrials.gov Identifier: NCT00050895 - Active, not recruiting
  HIV Infections
  
• Extended Safety Study of Tenofovir Disoproxil Fumarate (TDF) Among HIV-1 Negative Men
  ClinicalTrials.gov Identifier: NCT00131677 - Active, not recruiting
  HIV Infection
  
• Evaluation of Efficacy of Ophthalmic Solution in Induced Allergic Conjunctivitis
  ClinicalTrials.gov Identifier: NCT00244543 - Active, not recruiting
  Allergic Conjunctivitis
  
• Evaluation of Efficacy of Ophthalmic Solution in Seasonal Allergic Conjunctivitis
  ClinicalTrials.gov Identifier: NCT00364091 - Active, not recruiting
  Allergic Conjunctivitis
  
• A Comparison of Two Anti-HIV Drug Regimens for Youth Who Have Failed Prior Therapy
  ClinicalTrials.gov Identifier: NCT00102206 - Active, not recruiting
  HIV Infections
  
• Anti-HIV Drugs During Pregnancy
  ClinicalTrials.gov Identifier: NCT00042289 - Active, not recruiting
  HIV Infections
  
• Evolution of L74V or K65R Mutations in VIremic Subjects on Tenofovir Disoproxil Fumarate (TDF) or Abacavir (ABC) (EVITA)
  ClinicalTrials.gov Identifier: NCT00312169 - Recruiting
  HIV Infections
  
• Late Phase 2 Study of OPC-12759 Ophthalmic Suspension
  ClinicalTrials.gov Identifier: NCT00475319 - Recruiting
  Dry Eye Syndromes
  
• Once-Daily PI/NNRTI Therapy Combinations for Treatment Naive, HIV Infected Patients in Resource-limited Conditions
  ClinicalTrials.gov Identifier: NCT00084136 - Active, not recruiting
  HIV Infections
  
• Quetiapine Fumarate (SEROQUEL) and Placebo in the Treatment of Acutely Ill Patients with Schizophrenia
  ClinicalTrials.gov Identifier: NCT00085891 - Completed
  Schizophrenia
  
• Emtricitabine/Tenofovir Disoproxil Fumarate for HIV Prevention in Men
  ClinicalTrials.gov Identifier: NCT00458393 - Recruiting
  HIV Infections
  
• Safety Study of Ophthalmic Solution in Healthy, Normal Volunteers
  ClinicalTrials.gov Identifier: NCT00223951 - Active, not recruiting
  Healthy Volunteers Eligible for Study; Drug Being Developed for Allergic Conjunctivitis
  
• Quetiapine Fumarate (SEROQUEL) Compared to Placebo in the Treatment of Adolescent Patients with Schizophrenia
  ClinicalTrials.gov Identifier: NCT00090324 - Completed
  Schizophrenia
  
• Using Drug Levels and Drug Resistance Testing to Select Effective Anti-HIV Drug Combinations in Patients With Drug-resistant HIV
  ClinicalTrials.gov Identifier: NCT00027339 - Active, not recruiting
  HIV Infections
  
• Quetiapine Fumarate (SEROQUEL) Compared to Placebo in the Treatment of Children and Adolescent Patients with Bipolar I Mania
  ClinicalTrials.gov Identifier: NCT00090311 - Completed
  Bipolar Disorder
  
• Examining The Efficacy, Safety And Improved Tolerability Of Travoprost BAK Free Ophthalmic Solution (Travatan-Z) Compared To Prior Prostaglandin Therapy
  ClinicalTrials.gov Identifier: NCT00444665 - Recruiting
  Glaucoma
  
• Evaluation and Treatment Protocol for Potential Research Participants With Inherited Ophthalmic Diseases
  ClinicalTrials.gov Identifier: NCT00559234 - Recruiting
  Cataract; Glaucoma; Retinitis Pigmentosa; Macular Degeneration; Strabismus
  
• A Study to Compare Tenofovir Versus Hepsera (Adefovir) for the Treatment of HBeAg Negative Chronic Hepatitis B
  ClinicalTrials.gov Identifier: NCT00117676 - Active, not recruiting
  Chronic Hepatitis B
  
• Study of Anti-HIV Therapy Intensification
  ClinicalTrials.gov Identifier: NCT00034086 - Active, not recruiting
  HIV Infections
  
• A Study to Compare Tenofovir versus Hepsera (adefovir) for the Treatment of Hepatitis Be Antigen (HBeAg) Positive Chronic Hepatitis B
  ClinicalTrials.gov Identifier: NCT00116805 - Active, not recruiting
  Chronic Hepatitis B
  
• Study Comparing Tenofovir Disoproxil Fumarate (TDF), Emtricitabine/TDF, & Entecavir in the Treatment of Chronic HBV in Subjects w/Decompensated Liver Disease.
  ClinicalTrials.gov Identifier: NCT00298363 - Recruiting
  Chronic Hepatitis B
  
• Nine Month Course of Anti-HIV Medications for People Recently Infected with HIV
  ClinicalTrials.gov Identifier: NCT00090779 - Recruiting
  HIV Infections
  
• Quetiapine Fumarate (SEROQUEL) used as an Adjunct to Mood Stabilizers in the Treatment of Bipolar I Disorders
  ClinicalTrials.gov Identifier: NCT00107731 - Completed
  Bipolar Disorder
  
• Repository for Inherited Eye Diseases
  ClinicalTrials.gov Identifier: NCT00378742 - Recruiting
  Retinitis Pigmentosa; Inherited Ophthalmic Diseases
  
• Using Device Delivering Ophthalmic Solution in a Spray Form Instead of Eye Drops
  ClinicalTrials.gov Identifier: NCT00565630 - Not yet recruiting
  Cataract
  
• Study of INS365 Ophthalmic Solution in a Controlled Adverse Environment in Patients with Dry Eye
  ClinicalTrials.gov Identifier: NCT00037661 - Completed
  Keratoconjunctivitis Sicca
  
• NNRTI- Versus PI-Containing Regimens for HIV Infected Women After They Have Taken Nevirapine to Prevent Mother-To-Child Transmission of HIV
  ClinicalTrials.gov Identifier: NCT00089505 - Recruiting
  HIV Infections
  
• Safety and Effectiveness of Tenofovir Disoproxil Fumarate (Tenofovir DF) Plus Other Anti-HIV Drugs in HIV-Infected Patients
  ClinicalTrials.gov Identifier: NCT00002450 - Completed
  HIV Infections
  
• Comparison of Three Anti-HIV Regimens to Prevent Nevirapine Resistance in Women who Take Nevirapine During Pregnancy
  ClinicalTrials.gov Identifier: NCT00099632 - Recruiting
  HIV Infections
  
• Safety Study of Bromfenac Ophthalmic Solution in Subjects With Diffuse Diabetic Macular Edema (DME) Refractory to Laser
  ClinicalTrials.gov Identifier: NCT00491166 - Recruiting
  Diabetic Macular Edema
  
• Study of Tenofovir Disoproxil Fumarate (TDF) for Prevention of HIV
  ClinicalTrials.gov Identifier: NCT00122486 - Completed
  HIV Infections
  
• Study of INS115644 Ophthalmic Solution in Subjects With Ocular Hypertension or Glaucoma
  ClinicalTrials.gov Identifier: NCT00443924 - Recruiting
  Ocular Hypertension; Open Angle Glaucoma
  
• A Compassionate Use Study of Tenofovir Disoproxil Fumarate as Treatment for HIV Infection
  ClinicalTrials.gov Identifier: NCT00002453 - Completed
  HIV Infections
  
• Evaluating Quetiapine Fumarate (SEROQUEL) in the Treatment of Alcohol Dependency in Patients with Bipolar Disorder
  ClinicalTrials.gov Identifier: NCT00114686 - Completed
  Bipolar Disorder; Alcoholism
  
• Safety and Efficacy Trial of the Use of Quetiapine Fumarate (SEROQUEL®) in the Treatment of Patients with Bipolar Depression
  ClinicalTrials.gov Identifier: NCT00060489 - Completed
  Bipolar Disorder; Depression, Bipolar
  
• Tenofovir Disoproxil Fumarate (TDF) in HIV-1 Patients Who Have Never Taken Anti-HIV Drugs
  ClinicalTrials.gov Identifier: NCT00016588 - Completed
  HIV Infections
  
• IOP Lowering Efficacy of Travoprost/Brinzolamide Fixed Combination Ophthalmic Suspension in Patients With Open-Angle Glaucoma or Ocular Hypertension
  ClinicalTrials.gov Identifier: NCT00527501 - Recruiting
  Open-Angle Glaucoma; Ocular Hypertension
  
• Effectiveness and Safety of Tiotropium Bromide Alone Vs Tiotropium Bromide and Formoterol Fumarate in Subjects with COPD
  ClinicalTrials.gov Identifier: NCT00139932 - Completed
  Pulmonary Disease, Chronic Obstructive
  
• Quetiapine Treatment for Symptoms Associated with Borderline Personality Disorder
  ClinicalTrials.gov Identifier: NCT00122070 - Recruiting
  Borderline Personality Disorder
  
• Neoadjuvant Carboplatin and Vincristine and Standard Local Ophthalmic Therapy in Treating Patients With Intraocular Retinoblastoma
  ClinicalTrials.gov Identifier: NCT00079417 - Recruiting
  intraocular retinoblastoma
  
• Phase IV study of TRAVATAN 0.004% in subjects with iris pigmentation changes
  ClinicalTrials.gov Identifier: NCT00047554 - Recruiting
  Open-Angle Glaucoma; Ocular Hypertension
  
• Systemic Vincristine, Carboplatin, and Etoposide, Subtenon Carboplatin, and Local Ophthalmic Therapy With or Without Low-Dose Radiation Therapy in Treating Children With Intraocular Retinoblastoma
  ClinicalTrials.gov Identifier: NCT00072384 - Recruiting
  intraocular retinoblastoma
  
• A Study Exploring an Induction-Maintenance Kaletra-Based Therapy Versus a Sustiva-Based Regimen in Previously Non-Treated, HIV-1/HCV Co-Infected Subjects
  ClinicalTrials.gov Identifier: NCT00121017 - Not yet recruiting
  HIV Infection; Hepatitis C
  
• Bioavailability of Bimatoprost Ophthalmic Solution in Human Aqueous.
  ClinicalTrials.gov Identifier: NCT00355446 - Completed
  Cataract
  
• Next Generation Ophthalmic Irrigating Solution Posterior Segment Study
  ClinicalTrials.gov Identifier: NCT00333203 - Completed
  Eye Diseases
  
• Safety and Efficacy of Next Generation Ophthalmic Irrigating Solution Compared to BSS Plus
  ClinicalTrials.gov Identifier: NCT00333268 - Completed
  Cataract
  
• Dose-Response Study of OPC-12759 Ophthalmic Suspension
  ClinicalTrials.gov Identifier: NCT00234078 - Completed
  Dry Eye Syndromes
  
• Study of Tenofovir Disoproxil Fumarate (TDF) for Prevention of HIV
  ClinicalTrials.gov Identifier: NCT00122512 - Terminated
  Human Immunodeficiency Virus
  
• Dose Finding of Quetiapine Fumarate 200mg vs 400mg in First Episode Psychosis
  ClinicalTrials.gov Identifier: NCT00449397 - Completed
  Psychosis
  
• Study of Mometasone Furoate/Formoterol Fumarate Inhalation Combination in Healthy Volunteers
  ClinicalTrials.gov Identifier: NCT00418509 - Completed
  Healthy
  
• Effect of Brimonidine Tartrate Ophthalmic Solution 0.15% on Pupil Diameter in Normal Eyes
  ClinicalTrials.gov Identifier: NCT00413751 - Completed
  Healthy
  
• Quetiapine Fumarate Bipolar Maintenance Monotherapy
  ClinicalTrials.gov Identifier: NCT00314184 - Completed
  Bipolar Disorder
  
• Safety and Tolerability of Ciclesonide and Formoterol Fumarate Inhaled Once Daily in Patients With Asthma (18 to 75 y) (BY9010/M1-506)
  ClinicalTrials.gov Identifier: NCT00314509 - Completed
  Asthma
  
• A Phase III Study of Brimonidine Tartrate Ophthalmic Solution, 0.15% in Patients with Open-Angle Glaucoma or Ocular Hypertension
  ClinicalTrials.gov Identifier: NCT00061529 - Completed
  Open-Angle Glaucoma; Ocular Hypertension
  
• Absorption of Brimonidine Ophthalmic Solution in the Aqueous Humor of Cataract Patients
  ClinicalTrials.gov Identifier: NCT00352807 - Completed
  Cataract
  
• Study of Difluprednate Ophthalmic Emulsion in the Treatment of Uveitis
  ClinicalTrials.gov Identifier: NCT00406887 - Completed
  Anterior Uveitis; Panuveitis
  
• Study of Difluprednate Ophthalmic Emulsion in the Treatment of Severe Uveitis
  ClinicalTrials.gov Identifier: NCT00407056 - Completed
  Uveitis; Panuveitis
  
• Study of Difluprednate Ophthalmic Emulsion in the Treatment of Uveitis
  ClinicalTrials.gov Identifier: NCT00405496 - Completed
  Anterior Uveitis
  
• Study of Difluprednate Ophthalmic Emulsion in the Treatment of Postoperative Inflammation
  ClinicalTrials.gov Identifier: NCT00406497 - Completed
  Inflammation
  
• Study of Difluprednate Ophthalmic Emulsion in the Treatment of Postoperative Inflammation
  ClinicalTrials.gov Identifier: NCT00407225 - Completed
  Inflammation
  
• Study of Difluprednate Ophthalmic Emulsion in Postoperative Inflammation
  ClinicalTrials.gov Identifier: NCT00406341 - Completed
  Inflammation
  
• Phase III Study of 0.1% Tacrolimus(FK506) Ophthalmic Suspension in Patients With Vernal Keratoconjunctivitis
  ClinicalTrials.gov Identifier: NCT00567762 - Completed
  Keratoconjunctivitis; Conjunctivitis
  
• Role of Metabolites in Nicotine Dependence (4) - 13
  ClinicalTrials.gov Identifier: NCT00000296 - Completed
  Tobacco Use Disorder
  
• Role of Metabolites in Nicotine Dependence (1) - 1
  ClinicalTrials.gov Identifier: NCT00000284 - Completed
  Tobacco Use Disorder
  
• Role of Metabolites in Nicotine Dependence (2) - 5
  ClinicalTrials.gov Identifier: NCT00000288 - Completed
  Tobacco Use Disorder
  
• Efficacy and Safety of Quetiapine Fumarate Sustained Release (SEROQUEL SR) in the Treatment of Major Depressive Disorders
  ClinicalTrials.gov Identifier: NCT00326144 - Completed
  Major Depressive Disorder
  
• Efficacy and Safety of Quetiapine Fumarate Sustained Release (SEROQUEL SR) in Combination With an Antidepressant in the Treatment of Major Depressive Disorders
  ClinicalTrials.gov Identifier: NCT00326105 - Completed
  Major Depressive Disorder
  
• Confirmatory Study of Seroquel® in the Treatment of Bipolar Depression
  ClinicalTrials.gov Identifier: NCT00083954 - Completed
  Bipolar Disorder
  
• Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo and Active Control in Major Depressive Disorder
  ClinicalTrials.gov Identifier: NCT00321490 - Completed
  Major Depressive Disorder
  
• A comparison of Seroquel vs. Risperidone in Schizophrenia
  ClinicalTrials.gov Identifier: NCT00034905 - Completed
  Schizophrenia
  
• Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo in Major Depressive Disorder
  ClinicalTrials.gov Identifier: NCT00320268 - Completed
  Major Depressive Disorder
  
• Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo in Generalized Anxiety Disorder
  ClinicalTrials.gov Identifier: NCT00329264 - Completed
  Generalized Anxiety Disorder
  
• Efficacy and Safety Study for Ecabet Ophthalmic Solution for Treating Dry Eye Syndrome
  ClinicalTrials.gov Identifier: NCT00198536 - Completed
  Dry Eye Syndromes
  
• A Comparison of Two Drug Combinations Used in HIV-Infected Patients Who Never Have Taken Anti-HIV Drugs
  ClinicalTrials.gov Identifier: NCT00005573 - Completed
  HIV Infections
  
• Study of Efficacy of Levofloxacin 0.5% Ophthalmic Solution Administered Three Times a Day for Bacterial Conjunctivitis
  ClinicalTrials.gov Identifier: NCT00565123 - Completed
  Bacterial Conjunctivitis